Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IBRUTINIB vs PALBOCICLIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IBRUTINIB vs PALBOCICLIB: Safety Overview

Metric IBRUTINIB PALBOCICLIB
Total FAERS Reports 75,087 91,024
Deaths Reported 12,580 11,066
Death Rate 16.8% 12.2%
Hospitalizations 24,920 13,442
Average Patient Age 71.2 yrs 66.0 yrs
% Female Patients 39.2% 97.7%
FDA Approval Date Aug 24, 2022 Feb 3, 2015
Manufacturer Pharmacyclics LLC Pfizer Laboratories Div Pfizer Inc
Route ORAL ORAL
Marketing Status Prescription Prescription